<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.0" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JPHIA</journal-id>
<journal-title-group>
<journal-title>Journal of Public Health in Africa</journal-title>
<abbrev-journal-title>J Public Health Afr</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2038-9922</issn>
<publisher>
<publisher-name>PAGEPress Publications, Pavia, Italy</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.4081/jphia.2023.2249</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Body composition of type 2 diabetes patients in Uganda: A case-control study</article-title>
</title-group>
<contrib-group><contrib contrib-type="author" corresp="yes">
<name><surname>Buyinza</surname><given-names>Ronald</given-names></name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Nsamba</surname><given-names>Jonathan</given-names></name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff008"><sup>8</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Muyingo</surname><given-names>Anthony</given-names></name>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Matovu</surname><given-names>Nicholas</given-names></name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Nabirye</surname><given-names>Gloria</given-names></name>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kantengwa</surname><given-names>Adellah</given-names></name>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Akandunda</surname><given-names>Sandra</given-names></name>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Sseguya</surname><given-names>Wenceslaus</given-names></name>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Mathews</surname><given-names>Elezebeth</given-names></name>
<xref ref-type="aff" rid="aff008"><sup>8</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label>Pharmacy Department, Mbarara Regional Referral Hospital, Mbarara, Uganda</aff>
<aff id="aff002"><label>2</label>Department of Clinical Research, Jeuticals Research and Consulting (U) Ltd., Kampala, Uganda</aff>
<aff id="aff003"><label>3</label>Diabetes Clinic, Mbarara Regional Referral Hospital, Mbarara, Uganda</aff>
<aff id="aff004"><label>4</label>Department of Community Health and Behavioural Sciences, <institution>School of Public Health, Makerere University</institution>, Kampala, Uganda</aff>
<aff id="aff005"><label>5</label>Centre for Public Health, <institution>Queens University Belfast</institution>, Belfast, United Kingdom</aff>
<aff id="aff006"><label>6</label>Department of Nursing, <addr-line>Faculty of Health Sciences</addr-line>, <institution>Busitema University</institution>, Busitema, Uganda</aff>
<aff id="aff007"><label>7</label>Diabetes Clinic, St. Francis Nsambya Hospital, Kampala, Uganda</aff>
<aff id="aff008"><label>8</label>Department of Public Health and Community Medicine, <institution>Central University of Kerala</institution>, Periya, <addr-line>India</addr-line></aff>
<author-notes>
<corresp id="cor1">Pharmacy Department, Mbarara Regional Referral Hospital, Mbarara, Uganda. <email>buyinzaronald@yahoo.com</email></corresp>
<fn fn-type="con"><p>Contributions: RB, conceptualization, data collection, analysis, writing of the manuscript, editing, proofreading; JN, data collection, analysis, writing of manuscript, editing, proofreading; AM, technical guidance and oversight; NM, data analysis, writing of manuscript, editing, proofreading; AK, SA, GN, data collection; WS, technical guidance, editing, proofreading; EM, technical advice and oversight. All the authors have read and approved the final version of the manuscript and agreed to be accountable for all aspects of the work.</p></fn>
<fn fn-type="conflict"><p>Conflict of interest: The authors declare no potential conflict of interest. Funding: This study was supported by a capacity building research grant extended through Mbarara Regional Referral Hospital and Mbarara University of Science and Technology 2020 by Hansjoerg Wyss and Massachusetts General Hospital.</p></fn>
<fn><p>Ethics approval and consent to participate: The study obtained ethical clearance from the Mbarara University of Science and Technology Research Ethics Committee (MUREC 1/7). Informed written consent was obtained from the participants. Privacy and confidentiality were maintained. Pregnant women were not enrolled due to a lack of evidence for the unborn child's safety regarding bioelectrical impedance. Informed consent: Informed written consent was obtained from the participants. Privacy and confidentiality were maintained.</p></fn>
<fn><p>Availability of data and materials: All data generated or analyzed during this study are included in this published article.</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>02</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<day>27</day>
<month>01</month>
<year>2023</year>
</pub-date>
<volume>14</volume>
<issue>1</issue>
<elocation-id>2249</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>06</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>06</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9;Copyright: the Author(s)</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Licensee PAGEPress, Italy</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
<license-p>This work is licensed under a Creative Commons Attribution NonCommercial 4.0 License (CC <uri xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">BY-NC 4.0</uri>).</license-p>
</license>
</permissions>
<abstract>
<sec><title>Introduction</title>
<p>The prevalence of obesity among people diagnosed with Type 2 Diabetes Mellitus (T2DM) has been widely documented. However, the specific composition of this bodyweight remains largely unknown. The study aimed to understand the body composition of T2DM patients using the bioelectric impedance analysis technique, comparing findings to sex and agematched controls.</p>
</sec>
<sec><title>Materials and Methods</title>
<p>A comparative case-control study was carried out among 139 known cases of Type 2 diabetes aged 18 to 78 years randomly sampled from the diabetic clinic of Mbarara Regional Referral Hospital. We matched them to 139 hospital controls who were healthy non-diabetic attendants. Body composition parameters were computed and summarized as medians and interquartile ranges. Differences in the medians of body composition parameters were further assessed using the Mann- Whitney U test. Fat-free and fat mass indices were derived to offer a precise estimation of body composition parameters adjusted for height differences among study participants.</p>
</sec>
<sec><title>Results</title>
<p>Cases had significantly higher median systolic blood pressure, pulse rate, weight, Body Mass Index (BMI), Waist-Hip Ratio (WHR), total fat percentage, fat mass amount, Fat Mass Index, visceral fat, and metabolic age than their counterparts, whereas controls had significantly higher median total body water percentage versus cases. The highest significant differences occurred in fat percentage composition (Cases: β: 6.9 (95% C.I: 4.4, 9.4); Controls: Ref) followed by visceral fat (Cases: β: 3.5 (95% C.I: 2.5, 4.4); controls: Ref) and Fat Mass Index (Cases: 95% C.I: 2.6 (95% C.I: 1.6, 3.7). Cases had significantly higher Fat Mass Index, visceral fat and fat percentage (all p&#x003C;0.05) than controls.</p>
</sec>
<sec><title>Conclusions</title>
<p>Routine assessment of body composition of T2DM patients needs to be done to assess the amount, type and pattern of weight gain to prevent increases in adiposity.</p>
</sec>
</abstract>
<counts>
<fig-count count="1"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="16"/>
<page-count count="6"/>
</counts>
</article-meta>
</front>
<body>
<sec id="sec1-1">
<title>Introduction</title>
<p>Type 2 Diabetes Mellitus (T2DM) is a common metabolic disorder associated with aberrations such as hyperglycaemia, hyperlipidaemia and obesity. While the underlying causes of T2DM are multifactorial, the cardinal features are a decline in insulin production by pancreatic beta cells and peripheral insulin resistance.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> The prevalence of overweight among people diagnosed with T2DM has persistently remained high over time.<sup><xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref></sup> This is partly attributed to adipocytes releasing excess fatty acids that are resistant to insulin action,<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> low levels of physical activity,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> poor dietary practices, <sup><xref ref-type="bibr" rid="ref6">6</xref></sup> and the lipogenic effects of anti-diabetic medicines,<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> among others.</p>
<p>Obesity, overweight and abnormal fat accumulation are critical precursors for T2DM. Following diagnosis and initiation of antidiabetic medications such as sulfonylureas, biguanides, and insulin therapy, patients still show a higher preponderance of weight gain,<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> further exacerbating the already poor glycaemic control. This, in turn, can undermine the goal of medical therapy to achieve tight glycaemic control without adverse weight changes among diabetic patients.</p>
<p>Evidence in Uganda shows a high rate of overweight among T2DM patients.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> Unfortunately, the specific composition of this bodyweight remains largely unknown. We are unsure whether it is fat mass or fat-free mass compartments. Since the quality of weight depends hugely on its composition, increases in fat mass have a negative side effect for many patients with diabetes who aim to achieve glycaemic control. Fat mass is strongly associated with increased cardiovascular risk,<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> while fat-free mass is associated with better glycaemic control, muscular strength, immunity and survival.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup></p>
<p>This study therefore aimed to understand the body composition of T2DM patients attending the diabetic clinic of Mbarara Regional Referral Hospital and compare it to sex and age-matched healthy controls. Understanding the body composition is essential in harnessing glycaemic control while avoiding the deliberating effects of weight gain and guiding targeted health and dietary advice.</p></sec>
<sec id="sec1-2">
<title>Materials and Methods</title>
<sec id="sec2-1">
<title>Study design</title>
<p>A comparative case-control study was carried out between December 2020 and March 2021.</p></sec>
<sec id="sec2-2">
<title>Study participants</title>
<p>We recruited 139 known cases of Type 2 diabetes aged 18 to 78 years randomly sampled from the diabetic clinic of Mbarara Regional Referral Hospital. We matched them to 139 sex and age hospital controls who were healthy non-diabetic healthy attendants. Participants who were pregnant women, patients with pacemakers, heart diseases and bodybuilders were excluded from participating in the study.</p></sec>
<sec id="sec2-3">
<title>Body measurements</title>
<p>Body composition was measured using a duo frequency Bioelectrical Impedance Machine (Tanita DC-430 MA TANITA Corporation, Tokyo, Japan). Bodyweight was measured on a Seca portable electronic scale to the nearest 0.1 kg and height to the nearest 0.1 cm. Bodyweight (kg) and height (cm) were measured with the subjects wearing light garments and standing erect, respectively.</p>
<p>Waist and hip circumferences were measured in the midline between the lower rib margin and the iliac crest and the widest diameter over the greater trochanters. Mid upper arm circumference was measured at the mid-point between the tip of the shoulder and the tip of the elbow. All measurements were taken using standard equipment&#x2019;s and protocol.</p>
<p>Physical activity was measured using the World Health Organisation Global Physical Activity Questionnaire.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> Data collection involving body composition and glucose measurements was done in the morning after an overnight fast. All data collection tools and equipment were pretested and calibrated before data collection. A team of well-trained health workers undertook measurements.</p></sec>
<sec id="sec2-4">
<title>Data analysis</title>
<p>We used descriptive statistics (frequencies and percentages, mean and standard deviation) to summarise participants&#x2019; sociodemographic and lifestyle characteristics stratified by the study arm. Associations between the study arm and the different sociodemographic and lifestyle characteristics were assessed using the chi-square test for categorical variables and independent sample ttests for continuous variables. We also applied the two-sample test for proportions to test differences in proportions of certain lifestyle practices among cases versus controls as appropriate.</p>
<p>Clinical and body composition parameters were computed and summarised as medians and Interquartile Range (IQR) due to the non-normality of the respective data established using the Shapiro- Wilk normality test. Differences in the medians of clinical and body composition parameters were further assessed using the Mann-Whitney U test. Fat-Free and Fat Mass Indices were derived (kilograms/height in metres<sup><xref ref-type="bibr" rid="ref2">2</xref></sup>)<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> to offer a precise estimation of body composition parameters adjusted for height differences among study participants.</p>
<p>Body composition parameters that showed statistically significant differences between cases and controls in the Mann-Whitney U tests were modelled in simple and multiple regression models to establish the differences in the mean of these parameters in patients versus controls. Initially, unadjusted beta coefficients were computed, and resultant findings comparing cases and controls were displayed using box plots. After that, these estimates were adjusted for Body Mass Index (BMI) and Waist To Hip Ratio (WHR) in model 1. Further adjustments for several sociodemographic characteristics and lifestyle variables were made to assess if statistically significant differences in body composition parameters of cases versus controls are retained (Model 2).</p></sec>
<sec id="sec2-5">
<title>Ethical considerations</title>
<p>The study obtained ethical clearance from the Mbarara University of Science and Technology Research Ethics Committee (MUREC 1/7). Informed written consent were obtained from the participants. Privacy and confidentiality were maintained. Pregnant women were not enrolled due to a lack of evidence for the unborn child&#x2019;s safety regarding bioelectrical impedance.</p></sec>
</sec>
<sec id="sec1-3">
<title>Results</title>
<p>A total of 278 participants were recruited and analyzed with a 1:1 ratio of the case to controls. Cases and controls did not significantly differ in mean age and sex distribution as these were matched at recruitment. The median (IQR) fasting blood glucose of the cases was 7.5 (3.9) mmol/L, while the median (IQR) random blood glucose of the controls was 6.2 (1.8) mmol/L. Cases had a median duration of diabetes of 4 years (IQR: 8). Cases were more likely to have a smaller household size and be physically inactive than controls (all p&#x003C;0.05). The rest of the demographic and lifestyle characteristics are presented in <xref ref-type="table" rid="table001">Table 1</xref>.</p>
<sec id="sec2-6">
<title>Demographic and lifestyle characteristics of the participants</title>
<p>Results from the comparison of several clinical and body composition parameters among cases and controls revealed that cases had significantly higher median systolic blood pressure, pulse rate, weight, BMI, WHR, total fat percentage, Fat Mass Amount, Fat Mass Index, visceral fat, and metabolic age compared to their counterparts. In contrast, controls had significantly higher median total body water percentage versus cases. There were no statistically significant differences between diastolic blood pressure, height, fat-free mass, fat-free mass index, skeletal muscle mass, bone mass, and basal metabolic rate among cases and controls (<xref ref-type="table" rid="table002">Table 2</xref>).</p>
<p>Simple linear regression was conducted to obtain unadjusted mean differences in body fat composition parameters between cases and age-sex matched controls. Results showed that the highest significant differences occurred in fat percentage composition (Cases: β: 6.9 (95% C.I: 4.4, 9.4); Controls: Ref) followed by visceral fat (Cases: β: 3.5 (95% C.I: 2.5, 4.4); controls: Ref) and Fat Mass Index [Cases: 95% C.I: 2.6 (95% C.I: 1.6, 3.7), Figure 1].</p>
<p>After adjustment for BMI and WHR (Model 1), cases still had significantly higher Fat Mass Index, visceral fat and fat percentage (all p&#x003C;0.05) compared to controls. Even after further adjustment for certain demographic and lifestyle variables (Model 2), no change in strength and direction of association was noticed between the cases and controls (<xref ref-type="table" rid="table003">Table 3</xref>).</p></sec>
</sec>
<sec id="sec1-4">
<title>Discussion</title>
<p>The study aimed to understand the body composition of Type 2 Diabetes patients compared to the healthy, closely matched controls. The findings of the study indicate that cases had a higher BMI and weight. Waist Hip Ratios, Fat Mass Index, visceral fat and higher metabolic age values than their healthy counterparts. These findings are similar to those from previous studies<sup><xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref13">13</xref></sup> where T2DM patients were overweight and had a higher BMI than their healthy counterparts. A recent study<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> observed a similar occurrence with higher fat mass among diabetic patients. Similarly, other authors<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> reported more visceral fat and total body fat in T2DM patients than in healthy controls.</p>
<p>The study also revealed that diabetic patients had significantly higher systolic median blood pressure and pulse rate than their healthy counterparts. This observation has been witnessed among people with diabetes since diabetes damages blood vessels causing the walls to stiffen, leading to elevated blood pressure. Studies show that there is twice the risk of developing blood pressure among people with diabetes than the healthy non-diabetic populations. Controlling blood pressure is of paramount importance among people with diabetes to prevent adverse outcomes such as metabolic syndrome, congestive heart failure, and stroke.<sup><xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref16">16</xref></sup></p>
<p>Despite the elevated levels of fat mass and high blood pressure, we observed that diabetic patients were less likely to be physically active, which does not support weight loss. Since physical inactivity is a primary risk factor for metabolic disorders, T2DM patients must be supported to engage in an active lifestyle that improves peripheral insulin sensitivity, decreases visceral fat, and improves glycaemic control.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup></p>
<fig id="fig001" position="anchor">
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jpha-14-1-2249-g001.jpg" mime-subtype="jpg"/>
</fig>
<p>Results from the study illustrate the need to manage weight gain among T2DM patients. Clinicians need to engage patients in health education sessions, equipping them with information on the risks and patterns of weight gain. Insulin-related weight gain has been attributed to the anabolic effects of high-dose insulin, low physical activity and appetite increases. Understanding the cause and pattern of weight gain at an early stage can revert these life-threatening complications among diabetic patients later in life. The assessment of body composition and pattern of body fat distribution is critical in understanding the body fat distribution to reduce complications associated with high adiposity among T2DM patients.</p>
<p>Among key strengths of this study include the use of robust methods of body composition analysis and statistical tests. To our knowledge, this is the first study to carry out a comprehensive assessment of body composition among T2DM patients and compare the results with sex and age-matched controls in Uganda.</p>
<table-wrap id="table001" position="anchor" orientation="portrait">
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jpha-14-1-2249-t001.jpg" mime-subtype="jpg"/>
</table-wrap>
<table-wrap id="table002" position="anchor" orientation="portrait">
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jpha-14-1-2249-t002.jpg" mime-subtype="jpg"/>
</table-wrap>
<table-wrap id="table003" position="anchor" orientation="portrait">
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jpha-14-1-2249-t003.jpg" mime-subtype="jpg"/>
</table-wrap>
</sec>
<sec id="sec1-5">
<title>Conclusions</title>
<p>Our results indicate that patients with T2DM, compared to healthy age and sex-matched controls, show a considerably higher fat mass level. Clinicians and other public health practitioners need to pay particular attention to these individual parameters when treating and managing T2DM patients. We hope that body composition assessment can be included as a primary anthropometric measure while managing metabolic derangements of Type 2 Diabetes in Uganda.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We thank our study participants, research assistants and clinic staff for their dedication and participation in the study.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label> <mixed-citation publication-type="journal"><collab>American Diabetes Association,</collab>. <article-title>Diagnosis and Classification of Diabetes Mellitus</article-title>. <source>Diabetes Care</source>. <year>2004</year> Jan 1;<volume>27</volume>(<issue>suppl 1</issue>):<fpage>s5</fpage>&#x2013;<lpage>10</lpage>.</mixed-citation></ref>
<ref id="ref2"><label>2.</label> <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daousi</surname> <given-names>C</given-names></name><name><surname>Casson</surname><given-names>IF</given-names></name><name><surname>Gill</surname> <given-names>GV</given-names></name><name><surname>MacFarlane</surname> <given-names>IA</given-names></name><name><surname>Wilding</surname><given-names>JPH</given-names></name><name><surname>Pinkney</surname> <given-names>JH</given-names></name></person-group>. <article-title>Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors</article-title>. <source>Postgraduate Medical Journal</source>. <year>2006</year> Apr;<volume>82</volume>(<issue>966</issue>):<fpage>280</fpage>.</mixed-citation></ref>
<ref id="ref3"><label>3.</label> <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhupathiraju</surname><given-names>SN</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name></person-group>. <article-title>Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications</article-title>. <source>Circulation research</source>. <year>2016</year> May 27;<volume>118</volume>(<issue>11</issue>):<fpage>1723</fpage>.</mixed-citation></ref>
<ref id="ref4"><label>4.</label> <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gastaldelli</surname><given-names>A</given-names></name><name><surname>Cusi</surname> <given-names>K</given-names></name><name><surname>Pettiti</surname> <given-names>M</given-names></name><name><surname>Hardies</surname> <given-names>J</given-names></name><name><surname>Miyazaki</surname> <given-names>Y</given-names></name><name><surname>Berria</surname> <given-names>R</given-names></name><etal/></person-group>. <article-title>Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects</article-title>. <source>Gastroenterology</source>. <year>2007</year> Aug;<volume>133</volume>(<issue>2</issue>):<fpage>496</fpage>&#x2013;<lpage>506</lpage>.</mixed-citation></ref>
<ref id="ref5"><label>5.</label> <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brugnara</surname><given-names>L</given-names></name><name><surname>Murillo</surname> <given-names>S</given-names></name><name><surname>Novials</surname> <given-names>A</given-names></name><name><surname>Rojo-Mart&#x00ED;nez</surname> <given-names>G</given-names></name><name><surname>Soriguer</surname> <given-names>F</given-names></name><name><surname>Goday</surname> <given-names>A</given-names></name><etal/></person-group>. <article-title>Low Physical Activity and Its Association with Diabetes and Other Cardiovascular Risk Factors: A Nationwide, Population-Based Study</article-title>. <source>PLOS ONE</source>. <year>2016</year> Aug 17;<volume>11</volume>(<issue>8</issue>):<fpage>e0160959</fpage>.</mixed-citation></ref>
<ref id="ref6"><label>6.</label> <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sami</surname><given-names>W</given-names></name><name><surname>Ansari</surname> <given-names>T</given-names></name><name><surname>Butt</surname><given-names>NS</given-names></name><name><surname>Hamid</surname> <given-names>MRA</given-names></name></person-group>. <article-title>Effect of diet on type 2 diabetes mellitus: A review</article-title>. <source>Int J Health Sci (Qassim)</source>. <year>2017</year>;<volume>11</volume>(<issue>2</issue>):<fpage>65</fpage>&#x2013;<lpage>71</lpage>.</mixed-citation></ref>
<ref id="ref7"><label>7.</label> <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaudhury</surname><given-names>A</given-names></name><name><surname>Duvoor</surname> <given-names>C</given-names></name><name><surname>Reddy</surname><given-names>Dendi VS</given-names></name><name><surname>Kraleti</surname> <given-names>S</given-names></name><name><surname>Chada</surname> <given-names>A</given-names></name><name><surname>Ravilla</surname> <given-names>R</given-names></name><etal/></person-group>. <article-title>Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management</article-title>. <source>Front Endocrinol [Internet]</source>. <year>2017</year> [cited 2021 Apr 3];8. Available from: <comment><ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.frontiersin.org/articles/10.3389/fendo.2017.00006/full">https://www.frontiersin.org/articles/10.3389/fendo.2017.00006/full</ext-link></comment></mixed-citation></ref>
<ref id="ref8"><label>8.</label> <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matovu</surname><given-names>N</given-names></name><name><surname>Matovu</surname><given-names>FK</given-names></name><name><surname>Sseguya</surname> <given-names>W</given-names></name><name><surname>Tushemerirwe</surname> <given-names>F.</given-names></name></person-group> <article-title>Association of dietary intake and BMI among newly diagnosed type 2 diabetes patients attending diabetic clinics in Kampala</article-title>. <source>BMC Nutr</source>. <year>2017</year> Dec;<volume>3</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>10</lpage>.</mixed-citation></ref>
<ref id="ref9"><label>9.</label> <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alshehri</surname><given-names>AM</given-names></name></person-group>. <article-title>Metabolic syndrome and cardiovascular risk</article-title>. <source>J Family Community Med</source>. <year>2010</year>;<volume>17</volume>(<issue>2</issue>):<fpage>73</fpage>&#x2013;<lpage>8</lpage>.</mixed-citation></ref>
<ref id="ref10"><label>10.</label> <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genton</surname><given-names>L</given-names></name><name><surname>Graf</surname><given-names>CE</given-names></name><name><surname>Karsegard</surname> <given-names>VL</given-names></name><name><surname>Kyle</surname><given-names>UG</given-names></name><name><surname>Pichard</surname> <given-names>C.</given-names></name></person-group> <article-title>Low fat-free mass as a marker of mortality in community-dwelling healthy elderly subjects†</article-title>. <source>Age and Ageing</source>. <year>2013</year> Jan 1;<volume>42</volume>(<issue>1</issue>):<fpage>33</fpage>&#x2013;<lpage>9</lpage>.</mixed-citation></ref>
<ref id="ref11"><label>11.</label> <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cleland</surname><given-names>CL</given-names></name><name><surname>Hunter</surname><given-names>RF</given-names></name><name><surname>Kee</surname> <given-names>F</given-names></name><name><surname>Cupples</surname><given-names>ME</given-names></name><name><surname>Sallis</surname> <given-names>JF</given-names></name><name><surname>Tully</surname><given-names>MA</given-names></name></person-group>. <article-title>Validity of the Global Physical Activity Questionnaire (GPAQ) in assessing levels and change in moderate-vigorous physical activity and sedentary behaviour</article-title>. <source>BMC Public Health</source>. <year>2014</year> Dec 10;<volume>14</volume>(<issue>1</issue>):<fpage>1255</fpage>.</mixed-citation></ref>
<ref id="ref12"><label>12.</label> <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nsamba</surname><given-names>J</given-names></name><name><surname>Lule</surname><given-names>SA</given-names></name><name><surname>Namara</surname> <given-names>B</given-names></name><name><surname>Zziwa</surname> <given-names>C</given-names></name><name><surname>Akurut</surname> <given-names>H</given-names></name><name><surname>Lubyayi</surname> <given-names>L</given-names></name><etal/></person-group>. <article-title>Effect of birth weight, exclusive breastfeeding and growth in infancy on fat mass and fat free mass indices in early adolescence: an analysis of the Entebbe Mother and Baby Study (EMaBs) cohort</article-title>. <source>AAS Open Res</source>. <year>2020</year> Jan 9;<volume>2</volume>:<fpage>11</fpage>.</mixed-citation></ref>
<ref id="ref13"><label>13.</label> <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owolabi</surname><given-names>LF</given-names></name><name><surname>Adebisi</surname> <given-names>S</given-names></name><name><surname>Danborno</surname> <given-names>B.</given-names></name></person-group> <article-title>Nigerian Journal of</article-title>. <year>2016</year>;(January).</mixed-citation></ref>
<ref id="ref14"><label>14.</label> <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abulmeaty</surname><given-names>MMA</given-names></name><name><surname>Aljuraiban</surname><given-names>GS</given-names></name></person-group>. <article-title>Body Composition and the Components of Metabolic Syndrome in Type 2 Diabetes : The Roles of Disease Duration and Glycemic Control</article-title>. <year>2020</year>;<fpage>1051</fpage>&#x2013;<lpage>9</lpage>.</mixed-citation></ref>
<ref id="ref15"><label>15.</label> <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solanki</surname><given-names>JD</given-names></name><name><surname>Makwana</surname><given-names>AH</given-names></name><name><surname>Mehta</surname> <given-names>HB</given-names></name><name><surname>Gokhale</surname><given-names>PA</given-names></name><name><surname>Shah</surname> <given-names>CJ</given-names></name></person-group>. <article-title>Body Composition in Type 2 Diabetes : Change in Quality and not Just Quantity that Matters</article-title>. <year>2015</year>.</mixed-citation></ref>
<ref id="ref16"><label>16.</label> <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grossman</surname><given-names>A</given-names></name><name><surname>Grossman</surname> <given-names>E.</given-names></name></person-group> <article-title>Blood pressure control in type 2 diabetic patients. Cardiovascular Diabetology</article-title>. <year>2017</year>;<fpage>1</fpage>&#x2013;<lpage>15</lpage>.</mixed-citation></ref>
</ref-list>
</back>
</article>
